- home
- article
- Iga Swiatek has been suspended for a month after testing positive for a banned drug
Iga Swiatek has been suspended for a month after testing positive for a banned drug
ai generated text
Iga Swiatek, the world No.2 tennis player, tested positive for trimetazidine (TMZ), a heart medication, due to contamination through the use of melatonin for sleep issues. The incident occurred in August. Her level of fault was assessed as being at the lowest end of the range for no significant fault or negligence. As a result, she received a one-month suspension.
This case is an important reminder for tennis players of the strict liability nature of the World Anti-Doping Code and the importance of players carefully considering the use of supplements and medications.
Once the source of the TMZ had been established, it became clear that this was a highly unusual instance of a contaminated product, which in Poland is a regulated medicine. However, the product does not have the same designation globally, and the fact that a product is a regulated medication in one country cannot of itself be sufficient to avoid any level of fault.
In the last 2.5 months I was subject to strict ITIA proceedings, which confirmed my innocence.
We also emphasize that athletes must take every precaution to verify the safety and compliance of all products they use, as even unintentional exposure to prohibited substances can have significant consequences.
The ITIA accepted that the positive test was caused by the contamination of a regulated non-prescription medication (melatonin), manufactured and sold in Poland that the player had been taking for jet lag and sleep issues, and that the violation was therefore not intentional.
sources
perspectives
countries
organizations
- 1.World Anti-Doping Agency
- 2.International Tennis Integrity Agency
- 3.Instagram
- 4.Women's Tennis Association
